CorMedix
CRMD
71 hedge funds and large institutions have $50.2M invested in CorMedix in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 6 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 15
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
18% more capital invested
Capital invested by funds: $42.5M → $50.2M (+$7.75M)
4% more funds holding
Funds holding: 68 → 71 (+3)
3% more call options, than puts
Call options by funds: $848K | Put options by funds: $826K
0.86% more ownership
Funds ownership: 25.79% → 26.66% (+0.86%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Elliott Investment Management
West Palm Beach,
Florida
|
+$4.65M |
| 2 |
BlackRock
New York
|
+$640K |
| 3 |
Two Sigma Advisers
New York
|
+$544K |
| 4 |
Millennium Management
New York
|
+$538K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$365K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wolverine Trading
Chicago,
Illinois
|
-$136K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$112K |
| 3 |
SG Americas Securities
New York
|
-$89K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$85K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$74K |
CRMD Hedge Fund Activity: Q3 2020 in Review
71 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2020, worth a combined $50.2M — up 18% from $42.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CRMD positions and 6 closed out — a net gain of 4 holders — while 26 added to existing stakes and 15 trimmed.
The largest buyer was Elliott Investment Management, adding an estimated $4.65M. The largest seller was Wolverine Trading, exiting entirely with an estimated $136K sold.
- 71 institutional investors held CorMedix (CRMD) as of Q3 2020, up from 68 in Q2 2020.
- Funds reported $50.2M of CorMedix stock for Q3 2020, up 18% quarter-over-quarter.
- 10 funds opened new CorMedix positions in Q3 2020 and 6 closed out, a net change of +4 holders.
- The largest CorMedix buyer in Q3 2020 was Elliott Investment Management, an estimated $4.65M added.
- The largest CorMedix seller in Q3 2020 was Wolverine Trading, an estimated $136K sold.
Based on aggregated 13F filings for Q3 2020.